Table 1.
Correlation Between lncRNA CRNDE Expression and Clinical Features (n = 66)
| Variable | lncRNA2 CRNDE Expression | p Value | |
|---|---|---|---|
| Low | High | ||
| Age | 0.807 | ||
| <60 | 13 | 17 | |
| ≥60 | 17 | 19 | |
| Gender | 0.794 | ||
| Male | 21 | 23 | |
| Female | 9 | 13 | |
| Smoking | 0.353 | ||
| Smoking | 26 | 27 | |
| No smoking | 4 | 9 | |
| Differentiation | 0.013 | ||
| Poor | 20 | 12 | |
| Well/moderate | 10 | 24 | |
| TNM stage | 0.001 | ||
| I–II | 23 | 13 | |
| IIIa | 7 | 23 | |
| Lymph metastasis | 0.000 | ||
| Absent | 23 | 8 | |
| Present | 7 | 28 | |
| Treatment response | 0.000 | ||
| Complete response + partial response | 22 | 5 | |
| Stable disease + progressive disease | 8 | 31 | |
Low/high by the sample median. Pearson chi-square test. A value of p < 0.05 was considered statistically significant.